levofloxacin has been researched along with streptonigrin in 1 studies
Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (streptonigrin) | Trials (streptonigrin) | Recent Studies (post-2010) (streptonigrin) |
---|---|---|---|---|---|
4,346 | 581 | 2,209 | 399 | 7 | 48 |
Protein | Taxonomy | levofloxacin (IC50) | streptonigrin (IC50) |
---|---|---|---|
protein-arginine deiminase type-4 | Homo sapiens (human) | 2.5 | |
Vif | Human immunodeficiency virus 1 | 10.82 | |
Tat | Human immunodeficiency virus 1 | 42.129 | |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 10.82 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 1.87 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 1.87 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 1.87 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 1.87 | |
Sentrin-specific protease 6 | Homo sapiens (human) | 5.2 | |
Sentrin-specific protease 2 | Homo sapiens (human) | 6.9 | |
Sentrin-specific protease 1 | Homo sapiens (human) | 0.52 | |
Protein-arginine deiminase type-3 | Homo sapiens (human) | 0.43 | |
Protein-arginine deiminase type-4 | Homo sapiens (human) | 2.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamaguchi, M; Iguchi, A; Kobayashi, S; Kobayashi, T; Maki, T; Sakamoto, N; Yoshikawa, M | 1 |
1 other study(ies) available for levofloxacin and streptonigrin
Article | Year |
---|---|
[Significance of the antimicrobial drug used to prevent febrile infection following prostate needle biopsy].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Biopsy, Needle; Fever; Fluoroquinolones; Humans; Infection Control; Levofloxacin; Male; Middle Aged; Prostate; Retrospective Studies; Streptonigrin | 2014 |